Ryser MD - Search Results

1

Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.

Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES. Ryser MD, et al. Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1316-1323. doi: 10.1158/1055-9965.EPI-18-1262. Epub 2019 Jun 11. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31186262 Free PMC article.

2

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.

Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES. Worni M, et al. Among authors: ryser md. J Natl Cancer Inst. 2015 Sep 30;107(12):djv263. doi: 10.1093/jnci/djv263. Print 2015 Dec. J Natl Cancer Inst. 2015. PMID: 26424776 Free PMC article.

3

Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.

Ryser MD, Worni M, Turner EL, Marks JR, Durrett R, Hwang ES. Ryser MD, et al. J Natl Cancer Inst. 2015 Dec 17;108(5):djv372. doi: 10.1093/jnci/djv372. Print 2016 May. J Natl Cancer Inst. 2015. PMID: 26683405 Free PMC article.

4

Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach.

Ryser MD, Lee WT, Ready NE, Leder KZ, Foo J. Ryser MD, et al. Cancer Res. 2016 Dec 15;76(24):7078-7088. doi: 10.1158/0008-5472.CAN-16-1054. Epub 2016 Oct 20. Cancer Res. 2016. PMID: 27913438 Free PMC article.

5

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.

Grimm LJ, Ryser MD, Partridge AH, Thompson AM, Thomas JS, Wesseling J, Hwang ES. Grimm LJ, et al. Among authors: ryser md. Ann Surg Oncol. 2017 Nov;24(12):3534-3540. doi: 10.1245/s10434-017-6018-9. Epub 2017 Aug 9. Ann Surg Oncol. 2017. PMID: 28795370 Free PMC article.

6

How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.

Ryser MD, Horton JK, Hwang ES. Ryser MD, et al. Ann Surg Oncol. 2018 Feb;25(2):354-355. doi: 10.1245/s10434-017-6128-4. Epub 2017 Nov 13. Ann Surg Oncol. 2018. PMID: 29134379 No abstract available.

7

Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ.

Grimm LJ, Ryser MD, Hyslop T. Grimm LJ, et al. Among authors: ryser md. JAMA Surg. 2018 Mar 1;153(3):290-291. doi: 10.1001/jamasurg.2017.5566. JAMA Surg. 2018. PMID: 29344621 No abstract available.

8

Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials.

Ryser MD, Gulati R, Eisenberg MC, Shen Y, Hwang ES, Etzioni RB. Ryser MD, et al. Am J Epidemiol. 2019 Jan 1;188(1):197-205. doi: 10.1093/aje/kwy214. Am J Epidemiol. 2019. PMID: 30325415 Free PMC article.

9

Cancer Outcomes in DCIS Patients Without Locoregional Treatment.

Ryser MD, Weaver DL, Zhao F, Worni M, Grimm LJ, Gulati R, Etzioni R, Hyslop T, Lee SJ, Hwang ES. Ryser MD, et al. J Natl Cancer Inst. 2019 Sep 1;111(9):952-960. doi: 10.1093/jnci/djy220. J Natl Cancer Inst. 2019. PMID: 30759222 Free PMC article.

10

Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.

Grimm LJ, Miller MM, Thomas SM, Liu Y, Lo JY, Hwang ES, Hyslop T, Ryser MD. Grimm LJ, et al. Among authors: ryser md. Radiology. 2019 Jul;292(1):77-83. doi: 10.1148/radiol.2019182599. Epub 2019 May 21. Radiology. 2019. PMID: 31112087 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters